
For Successor Physicians
You Trained 12 Years in Ophthalmology. PE Made You a Salesman.
Count the years. 4 years of college, 4 years of medical school, a year of internship, and 3 years of residency put you at 12 before the operating room was truly yours, and most of you stacked a fellowship on top of that. The private equity pitch that recruited you promised the reward for all of it in a single sentence: just practice medicine, and we'll handle the business. Then the first quarterly review arrived with a growth target next to your name, and the people who promised to take the business off your plate handed you a quota and called it alignment.
The Pitch Was Relief, and Wanting It Was Rational
Nobody goes through 12 years of training because they dream of negotiating payer contracts, managing front desk turnover, or arguing with a billing clearinghouse. The exhaustion physicians feel around the business of medicine is real and measurable, and private equity built its entire recruiting engine on top of it. The pitch says you'll walk in, operate, see patients, and go home while professionals handle everything else, and for a surgeon staring at the administrative side of American medicine, that offer sounds like oxygen.
Wanting that relief was a rational decision, and choosing it says nothing embarrassing about you. The problem was never your judgment. The problem is that the relief was the bait, and the actual product was something else entirely.
The Switch Arrived After the Ink Dried
Ophthalmology Management reported in 2025 that physicians in PE-owned practices are expected to support priorities set by nonmedical personnel, even when those priorities mean heavier patient loads or steering volume toward costlier procedures. The clinical schedule you thought you'd escaped into turns out to be an instrument that somebody in a different city tunes for yield.
Dr. John Hagan, an ophthalmologist writing in KevinMD in December 2025 about acquired practices in his own market, described what the tuning looks like from inside: encounter times capped around 15 minutes, referrals required to stay inside the group, raised fees, higher billing expectations, more surgery, and physicians who repeatedly miss their quotas getting pilloried, threatened, and sometimes fired. Hold that last clause up against the pitch that recruited you. You were promised freedom from the business, and what you received was the sales floor, complete with a production board and a manager who's never held an instrument.
They Bought You for Your Volume
The targeting was never random. KFF Health News found in 2022 that private equity held investments in 43% of the top Lucentis prescribers in the country while owning stakes in only 8% of ophthalmologists overall. Funds buy the physicians who produce, and once the purchase closes, the model only works if the production grows every quarter, because the whole platform is being fattened for a resale on a 3 to 5 year clock.
That reframes what happened to you. You believed you were hired to be a surgeon. The spreadsheet says you were acquired as a revenue line with a growth assumption attached, and every marketing expectation, referral directive, and volume review you've absorbed since is the growth assumption collecting what it was promised. The fund never needed you to feel like a salesman. The fund only needed you to sell.
And the injury runs deeper than the workload, because it lands on your identity. Surgeons build their sense of self on mastery, on the 10,000 hours behind a slit lamp and a microscope, and on the trust patients place in that mastery. A quota converts all of it into a sales metric. The day a regional manager rates your quarter, the thing being rated stopped being your surgery a long time ago, and every physician inside these platforms feels that shift whether or not anyone names it out loud.
The Hours Tell On Them
The AMA surveyed roughly 19,000 physicians across 106 health systems in 2024 and found an average workweek of 57.8 hours, with 7.3 of those hours going to pure administrative tasks and another 13 to indirect patient care. The same body of AMA research produced an even bleaker calculation, estimating that a physician would need nearly 27 hours in a day to complete all recommended patient care plus the administrative requirements stacked on top of it. The overflow has a name inside medicine, and the name is pajama time, because the charts follow you home. Burnout came in at 43.2% for 2024, and the honest reading of that number is that it has been trending down from the pandemic peak and still means nearly half of American physicians report at least 1 symptom, with employed physicians consistently faring worse than owners.
You joined a platform to get those hours back, and instead the administrative load stayed while a new layer landed on top of it. Now the week includes marketing yourself to referral sources, protecting relationships with the optometrists who feed the surgical schedule, sitting through production reviews, and explaining variances to people who read your OR day as a line chart. The business you fled followed you in the door, and it brought a quota with it.
The Only Part of Business They Kept for Themselves Was the Upside
Here's the cut that should make you angriest, because it's the one hiding in plain sight. A business owner accepts risk and pressure in exchange for upside and control, and an employee trades upside away in exchange for stability and relief. Private equity engineered a 3rd category just for physicians, one that combines the obligations of an owner with the paycheck of an employee. You carry the growth pressure, the marketing burden, and the accountability for volume, while the equity value created by your production accrues to a fund that will sell your practice to another fund before your next contract renewal.
Trace where everything went. The founder who sold the practice got the multiple, and part of that multiple was priced on your future production. The fund gets the growth you generate and the proceeds of the next flip. You got the quota, the 15 minute slots, and a t-shirt at the rebranding town hall. Everyone in the chain monetized your 12 years of training except the person who did the training.
Growth Should Pay the Person Growing It
The rage this produces in surgeons is justified, and it's also useful, because it points directly at the fix. The problem was never that somebody handles the business around you. The problem is who captures the value when the business grows, and the fix is a structure where the answer is you.
At Verdira the successor physician owns the professional corporation outright, and you put in $0 to get there. There's no buy-in to save toward, no practice loan, and no note with your name on it. We operate as the management organization underneath you, which means the marketing, billing, staffing, credentialing, and growth work that PE quietly pushed onto your shoulders sits on ours instead, in writing, as our contractual job. When the panel grows and the surgical volume climbs, the growth pays the owner, because the owner owns the thing that grew, and under our model the owner is you.
You spent 12 years learning to operate at the highest level medicine offers. You should spend the next 25 being paid like the person the entire building depends on, because that was always the truth of it, and the only thing PE ever added to that truth was a middleman collecting your share. Run your numbers, look at the owned version of your own career, and stop selling for people who couldn't assist on a single case you've ever done.
Educational material only. Figures are illustrative and individual results vary. Images are AI-generated illustrations and don't depict actual Verdira practices, physicians, or patients. See our Disclosures.
Written by
Verdira Team
Verdira is building a permanent home for ophthalmology practices. We write about succession, physician ownership, and the forces reshaping eye care in the United States.
Ready to secure your legacy?
We're here to ensure your hard work is valued and your business thrives as part of Verdira.
Disclosures
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
© 2026 Verdira Management NY, LLC
